中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

682 records (took 0.034 seconds)

    Random Mat and Fiber-Reinforced Composite Material
    111.
    发明申请
    Random Mat and Fiber-Reinforced Composite Material 有权
    随机垫和纤维增强复合材料

    公开(公告)号：US20130317161A1

    公开(公告)日：2013-11-28

    申请号：US13956417

    申请日：2013-08-01

    Applicant: Teijin Limited

    Inventor： Yuhei Konagai ,  Naoaki Sonoda ,  Noboru Okimoto ,  Katsuyuki Hagihara

    IPC: C08K3/04

    CPC classification number: C08K3/04 ,  B29B11/16 ,  B29C43/222 ,  B29C70/12 ,  C08J5/042 ,  C08J2300/22 ,  D04H1/4242 ,  D04H1/60 ,  D04H1/732

    Abstract: There is provided a random mat of the present invention including: reinforcing fibers having an average fiber length of 5 to 100 mm; and a thermoplastic resin, wherein a fiber areal weight of the reinforcing fibers is from 25 to 3,000 g/m2, for a reinforcing fiber bundle (A) including the reinforcing fibers equivalent to or more than a critical single fiber number defined by formula (1), a ratio of the reinforcing fiber bundle (A) to a total amount of the reinforcing fibers in the mat is from 30 vol % to less than 90 vol %, and an average number (N) of the reinforcing fibers in the reinforcing fiber bundle (A) satisfies formula (2): Critical single fiber number=600/D   (1) 0.7×104/D2

    Abstract translation: 提供本发明的无规毡，其包括：平均纤维长度为5〜100mm的增强纤维; 以及热塑性树脂，其中，对于包含等于或大于由式（1）定义的临界单纤维数的增强纤维的增强纤维束（A），增强纤维的纤维面积重量为25〜3,000g / m 2 ），增强纤维束（A）与垫子中的增强纤维的总量的比例为30体积％〜小于90体积％，增强纤维中的增强纤维的平均数（N） 束（A）满足式（2）：临界单纤维数= 600 / D（1）0.7×104 / D2

    Powdery composition for nasal administration
    114.
    发明申请
    Powdery composition for nasal administration 失效
    用于鼻腔给药的粉状组合物

    公开(公告)号：US20040219108A1

    公开(公告)日：2004-11-04

    申请号：US10860058

    申请日：2004-06-04

    Applicant: TEIJIN LIMITED

    Inventor： Masahiko Dohi ,  Yoshihisa Nishibe ,  Yuji Makino ,  Tako Fujii

    IPC: A61L009/04 ,  A61K009/14

    CPC classification number: A61K9/0043

    Abstract: A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxypropyl cellulose or hydroxypropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or null-cellulose, (2) wherein the amount of the water-absorbing and gel-forming base material is about 5-40 wt % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material.

    Abstract translation: 一种用于鼻腔给药的粉末组合物，其中（1）组合物包含（i）药物，（ii）吸水和凝胶形成基材如羟丙基纤维素或羟丙基甲基纤维素和（iii）吸水和水 - 不溶性基材如结晶纤维素或α-纤维素，（2）其中吸水和凝胶形成基材的量相对于吸水和凝胶形成的总量为约5-40重量％ 基材和吸水性和水不溶性基材，和（3）其中药物在吸水性和水不溶性基材中/吸水凝胶形成中的/不均匀分散 基材。

    Bladder and tire producing method
    117.
    发明申请
    Bladder and tire producing method 失效
    膀胱和轮胎生产方法

    公开(公告)号：US20030122284A1

    公开(公告)日：2003-07-03

    申请号：US10285426

    申请日：2002-11-01

    Applicant: TEIJIN LIMITED

    Inventor： Hiroyuki Mori ,  Yozaburo Takayama ,  Kazuhisa Fujisawa ,  Hisashi Mitamura ,  Kazuto Okada ,  Naoya Fujiwara ,  Eiichiro Yoshikawa ,  Takayuki Kogishi

    IPC: B29D029/00

    CPC classification number: B29C43/3642 ,  B29C33/505 ,  B29C43/104 ,  B29C2043/3649 ,  B29D30/0601 ,  B29D30/0654 ,  B29D2030/0655 ,  B29L2030/00

    Abstract: An object of the present invention is to provide a bladder which is unlikely to have a shapal variation along the inner wall surface of the tire and can satisfactorily extend along the inner wall surface of the tire. An inventive bladder is used to press the inner wall surface of the tire by a pressurized heating medium during the vulcanization of a green tire and is comprised of a fabric layer (purl stitched fabric layer 12) and rubber layers (silicone rubber layers 11, 13) placed one over another. Elongation rates of the fabric layer in warp direction and in weft direction both exceed 15% and satisfy: 0.4nullelongation rate in weft direction/elongation rate in warp directionnull6.0. Since the fabric layer has good extensibility, it can elongate with the rubber layers.

    Abstract translation: 本发明的目的是提供一种不太可能沿着轮胎的内壁表面形成变形的气囊，并且能够令人满意地沿着轮胎的内壁表面延伸。 本发明的气囊用于在生胎硫化期间由加压加热介质挤压轮胎的内壁表面，并且由织物层（缝合织物层12）和橡胶层（硅橡胶层11,13 ）放在一个另一个。 织物层在经向和纬向上的伸长率均超过15％，满足：0.4 <=纬向伸长率/经向伸长率<= 6.0。 由于织物层具有良好的延展性，它可以用橡胶层延长。

    Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
    118.
    发明申请
    Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same 失效
    维生素D3衍生物和用于炎性呼吸系统疾病的治疗剂

    公开(公告)号：US20020091109A1

    公开(公告)日：2002-07-11

    申请号：US10035219

    申请日：2002-01-04

    Applicant: TEIJIN LIMITED

    Inventor： Kazuya Takenouchi ,  Qingzhi Gao ,  Kenji Manabe ,  Ryo Sogawa ,  Yasuhiro Takano ,  Seiichi Ishizuka

    IPC: A61K031/59 ,  C07C401/00 ,  C07C403/00

    CPC classification number: C07C401/00 ,  C07F7/1804 ,  Y02P20/55

    Abstract: Compounds expressed by the following general formula (1), 1 nullwherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1), (1-2), (1-3), (1-4) and (1-5)null. 2 The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.

    Abstract translation: 由以下通式（1）表示的化合物[其中，R 01和R 02各自独立地为氢原子或羟基的保护基; Z为下式（1-1），（1-2），（1-3），（1-4）和（1-5）中的一个）。 该化合物可用作炎性呼吸系统疾病，恶性肿瘤，类风湿性关节炎，骨质疏松症，糖尿病，高血压，脱发，痤疮，牛皮癣，皮炎，高钙血症，甲状旁腺功能低下和软骨代谢紊乱的治疗剂的活性成分。

Patent Agency Ranking